Morphine Sulfate Capsule, Extended Release
Product Images NDC 0228-3093

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Morphine Sulfate (NDC 0228-3093). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Morphine sulfate extended-release oral capsules in a bottle with a child-resistant cap. The label includes the proprietary and generic name, product strength (30 mg), dosage form, oral route, and manufacturer Actavis Pharma, Inc. The bottle is amber-colored with a white cap and a printed white and orange label containing drug information and warnings in black text.*

FDA Label Image

Image 10

Morphine sulfate 120 mg extended-release capsules in a clear amber bottle with a white child-resistant cap. The label on the bottle includes the drug name, strength, dosage form, and the labeler Actavis Pharma, Inc. The bottle contains multiple capsules visible inside.*

FDA Label Image

Image 11

Label for Morphine sulfate extended release oral capsules, showing six different capsule strengths: 30 mg, 45 mg, 60 mg, 75 mg, 90 mg, and 120 mg. Each capsule strength is represented by a distinct color scheme and printed dosage on the capsule body. The labeler is Actavis Pharma, Inc.*

FDA Label Image

Image 12

Morphine sulfate 15 mg extended release capsules. The capsule is white with black text on one half and black on the other half. Displayed is a close-up of a single capsule used for oral administration.*

FDA Label Image

Image 13

Morphine sulfate 90 mg extended-release oral capsules blister pack. The image shows a red plastic blister containing 10 capsules with alternating hollow and solid end caps. The capsules appear brown and opaque, arranged in two rows of five capsules each.*

FDA Label Image

Image 14

Morphine sulfate 120 mg extended release oral capsules carton from Actavis Pharma, Inc. The front of the box displays the product name, strength, dosage form, and the labeler information.*

FDA Label Image

Image 15

An instructional illustration depicting hands pouring extended-release capsules into a spoon. The image emphasizes proper handling of the capsule dosage form for oral administration, associated with Morphine sulfate capsules.*

FDA Label Image

Image 16

An instructional diagram showing a person using a cotton swab or applicator to apply or insert a product into their mouth. The image focuses on the facial profile and the hand holding the applicator near the lips.*

FDA Label Image

Image 17

An instructional illustration showing a person holding a glass of water near their mouth, demonstrating the oral administration of a medication.*

FDA Label Image

Image 18

An instructional illustration showing a hand placing a capsule into a device, possibly a medication dispenser or a container. This type of image is typically used to demonstrate the proper handling or administration of a capsule dosage form.*

FDA Label Image

Image 19

Label for Morphine Sulfate Extended-Release Capsules, USP 30 mg, with a quantity of 100 capsules. The label includes dosage instructions, warnings to not crush, chew, or dissolve, storage conditions, and pharmacist dispensing guidance. Manufactured for Teva Pharmaceuticals, Parsippany, NJ. NDC 0228-3090-11 is visible along with a barcode and serialization coding area.*

FDA Label Image

Image 2

Morphine sulfate 120 mg extended-release oral capsules in a white and gray blister pack. The blister pack contains 10 capsules arranged in two rows of five. Each capsule is white and imprinted with the number 120. No additional labeler or branding details are shown on the blister pack.*

FDA Label Image

Image 20

Label for Morphine Sulfate Extended-Release Capsules, USP, 45 mg strength. The label indicates a 100-capsule count, with directions to dispense the accompanying medication guide to each patient. It includes storage instructions, dosage form as capsules, and highlights the manufacturer as Teva Pharmaceuticals. The label features a barcode and serialization coding area.*

FDA Label Image

Image 21

Label for Morphine Sulfate Extended-Release Capsules, USP 60 mg, oral dosage form. The label indicates 100 capsules per container, prescription use only, and provides dosage and storage instructions. Manufactured for Teva Pharmaceuticals, Parsippany, NJ. The label includes the NDC number 0228-3091-11.*

FDA Label Image

Image 22

Label for Morphine Sulfate Extended-Release Capsules, USP, 75 mg strength, oral dosage form. The label states the product is for once daily use and contains 100 capsules. It instructs pharmacists to dispense the accompanying Medication Guide and includes storage information along with manufacturer details (Teva Pharmaceuticals, Parsippany, NJ). The label also features NDC 0228-3117-11 and a barcode.*

FDA Label Image

Image 23

Label for Morphine Sulfate Extended-Release Capsules, USP 90 mg, oral dosage form by Teva Pharmaceuticals. The label states it is for opioid-tolerant patients only, contains 100 capsules, and requires dispensing with a medication guide. It includes storage instructions and cautions such as not crushing, chewing, or dissolving the capsules.*

FDA Label Image

Image 24

Label for Morphine Sulfate Extended-Release Capsules, USP 120 mg, manufactured by Teva Pharmaceuticals. The label indicates it contains 100 capsules, is for opioid-tolerant patients only, and is dispensed with a medication guide. Storage and handling instructions, dosage information (once daily), and warnings are included along with a barcode and serialization coding area.*

FDA Label Image

Image 3

Morphine sulfate extended-release capsules packaging showing multiple capsule strengths: 120 mg, 30 mg, 45 mg, 60 mg, 75 mg, and 90 mg. The capsules are orange to light orange in color with printed imprint codes. The labeler is Actavis Pharma, Inc. Capsules are intended for oral administration.*

FDA Label Image

Image 4

Morphine sulfate extended release capsules in a clear plastic bottle with a child-resistant white cap. The label shows the prescription drug name, strength (not legible in image), and the manufacturer as Actavis Pharma, Inc. The bottle is designed for oral use and is part of the 30 mg strength label set.*

FDA Label Image

Image 5

Morphine sulfate 30 mg extended-release oral capsules in a white and green blister pack manufactured by Actavis Pharma, Inc. The capsules are arranged in a single row with clear labeling on each capsule showing the dosage strength '30 mg'.*

FDA Label Image

Image 6

Morphine sulfate 120 mg extended-release oral capsules packaging label. The label shows the product name, strength, dosage form, quantity count of 90 capsules, and the Actavis Pharma, Inc. labeler name. The label includes directions to prevent accidental overdose from children.*

FDA Label Image

Image 7

Chemical structure diagram showing the molecular composition of Morphine sulfate, indicating sulfate and water molecules as part of the structure.*

FDA Label Image

Image 8

A line graph comparing plasma concentration (ng/ml) over 24 hours between Morphine Sulfate Extended-Release Once-Daily and Morphine solution administered 6 times daily. The x-axis represents time in hours, and the y-axis shows plasma concentration. Data points are depicted with squares for extended-release and circles for solution.*

FDA Label Image

Image 9

Morphine sulfate extended-release capsules packaging label showing capsules in two colors, dark red and green, with printed numeric markings on each. The label indicates oral administration and includes the labeler name Actavis Pharma, Inc., featuring a tightly packed blister card layout of multiple capsules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.